|
Hope for people with leading cause of blindness is the headline for a story running in community papers across the U.S. The story highlights results of the Lutein Antioxidant Supplementation Trial (L.A.S.T.), a landmark study published in the Journal of the American Optometric Association that showed improvement of visual function among age-related macular degeneration (AMD) patients who took a daily 10-mg lutein supplement.**
|
